THE DEFINITIVE GUIDE TO API PHARMACEUTICAL

“The existing situation has uncovered some structural weaknesses during the EU’s medicines provide chain as well as a high dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides stated. She encouraged that supply chain issues be resolved within an EU pharmaceutical technique expected to become introduced by the tip